News
Macula Densa Cell LLC has a patent entitled “Targeting macula densa cells as a new therapeutic approach for kidney disease” (US patents 10,828,374 and 11,318,209).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback